In a population-based cohort study, Waresnjo et al have shown the altered serum fatty acid composition due to SCD1 (Δ9), Δ5 and Δ6desaturase activities and its association with the metabolic syndrome and thereby suggesting that altered serum fatty acid composition may predict the development of metabolic syndrome [15]. The gene discussed is SCD; the disease is metabolic syndrome.